Evidence map›Paper›PMID 42502996›Full record

ArticleJournal of evaluation in clinical practice2026

Sequential Screening as Diagnostic Filtering or Substitution: A Bayesian Cost Model of Screening as a Function of Prevalence.

Eva Mamane, Jacques Balayla

Abstract read
In one paragraph

Article in Journal of evaluation in clinical practice, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Eva MamaneFaculty of Medicine, Université de Sherbrooke, Sherbrooke, Quebec, Canada.
Jacques BalaylaLady Davis Institute (LDI), Jewish General Hospital, Montreal, Quebec, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveIn low-prevalence settings, standard screening cascades may generate many false-positive referrals for confirmatory testing, increasing cost, delay, and patient burden. We develop a Bayesian cost model comparing the standard cascade with two sequential architectures: substitution, in which repeated screening replaces immediate confirmation, and filtering, in which repeated screening narrows the group referred for confirmation.

methodsFor disease prevalence

resultsPersistent positivity compounds evidence by replacing

conclusionsSequential screening is a prevalence-dependent design choice, not a universal substitute for diagnosis. Filtering is more clinically conservative because it preserves confirmation while reducing referrals. Substitution is appropriate only when repeated measurements are already embedded in accepted diagnostic standards.

Indexed as

Mass ScreeningBayes TheoremFalse Positive ReactionsHumansPrevalenceSensitivity and SpecificityBayesian updatingcost per true positivefalse positiveslikelihood ratiopositive predictive valueprevalence thresholdscreening designsequential screeningserial testing

Identifiers

PMID42502996
PMCPMC13401866

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.